The four pillars of our Commitment
We recognize the importance of patients and caregivers understanding what they can expect from Novartis.
Novartis annually discloses monetary and non-monetary support to patient organizations around the globe by June 30.
in general medicines obtained patient insights before first-in-human trials (healthy volunteers).
94% requests approved for 55 compounds in 80 countries - providing access to locally unlicensed Novartis medicines. At the end of 2022, more than 9 700 patients were receiving treatment through MAPs.
comprising 85 clinical trials, had a patient engagement component to obtain the patient perspective on the design and/or conduct of clinical trials.
included Patient Reported Outcomes (PRO) conducted in 77 countries.
from Phase 1-4 clinical trials sent to investigators to share with 35 500 trial participants and posted on novartis.com/clinicaltrials.
reached through access programs.
Novartis Managed Access makes investigational or unapproved treatments available to eligible patients with serious or life-threatening diseases. Your physician may request access.
Diversity in clinical trials is integral to who we are at Novartis and we are working hard to improve both the diversity of patients enrolled in our clinical research and the investigators involved in our trials. (PDF 0.2 MB)
Global Oncology Patient Insights Panels (GOPIPs) are giving patients and advocates a critical voice in advancing lung cancer trials.
We collaborate with patient organizations and healthcare organizations globally in the disease areas for which we provide or are developing medicines. This collaboration is based on values of mutual respect, trust and transparency.
Novartis may provide funding to legitimate organizations to support its mission to discover new ways to improve and extend people's lives, advancing scientific and medical knowledge, and supporting the communities where Novartis Associates live and work.
We commit to actively seeking out and listening to insights from the patient community. Visit our YouTube channel to watch our Patient & Caregiver stories and learn more about our resources.
For questions about Novartis, medical inquiries about our products and/or information about services, we recommend you contact the Novartis office in your country. If you’re seeking a global list of products, visit our Global Product Portfolio.